Cargando…
Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial
BACKGROUND: The prevalence of chronic suppurative lung disease (CSLD) and bronchiectasis unrelated to cystic fibrosis (CF) among Indigenous children in Australia, New Zealand and Alaska is very high. Antibiotics are a major component of treatment and are used both on a short or long-term basis. One...
Autores principales: | Valery, Patricia C, Morris, Peter S, Grimwood, Keith, Torzillo, Paul J, Byrnes, Catherine A, Masters, I Brent, Bauert, Paul A, McCallum, Gabrielle B, Mobberly, Charmaine, Chang, Anne B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445847/ https://www.ncbi.nlm.nih.gov/pubmed/22891748 http://dx.doi.org/10.1186/1471-2431-12-122 |
Ejemplares similares
-
Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial
por: Chang, Anne B, et al.
Publicado: (2013) -
Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial
por: Goyal, Vikas, et al.
Publicado: (2018) -
Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol
por: Chang, Anne B, et al.
Publicado: (2011) -
Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
por: Goyal, Vikas, et al.
Publicado: (2019) -
Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial
por: Chang, Anne B, et al.
Publicado: (2012)